SOW
STLN

State of Wyoming’s Starling Oncology STLN Stock Holding History

State of Wyoming’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
72,882
-30,735
-30% -$129K 0.04% 536
2026
Q1 		$318K Sell
103,617
-3,056
-3% -$9.37K 0.04% 638
2025
Q4 		$380K Buy
106,673
+43,688
+69% +$162K 0.04% 560
2025
Q3 		$220K Buy
62,985
+44,937
+249% +$154K 0.03% 872
2025
Q2 		$37K Buy
+18,048
New +$45.1K ﹤0.01% 1630
2022
Q2 		– Sell
-967
Closed -$7K – 2138
2022
Q1 		$7K Buy
+967
New +$6.52K ﹤0.01% 1642

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State of Wyoming's STLN Position: Q2 2026 in Review

State of Wyoming reduced its Starling Oncology (STLN) stake by 30% in Q2 2026, selling an estimated $129K and leaving 72,882 shares worth $396K. The position accounts for 0.04% of the portfolio, ranked #536.

State of Wyoming first reported a position in STLN in Q1 2022 and has held it in 6 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • State of Wyoming held 72,882 shares of Starling Oncology worth $396K as of Q2 2026.
  • State of Wyoming sold 30,735 Starling Oncology shares in Q2 2026, an estimated $129K.
  • Starling Oncology made up 0.04% of State of Wyoming's portfolio in Q2 2026, its #536 holding.
  • State of Wyoming first reported a position in Starling Oncology in Q1 2022 and has held it in 6 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.